nftwemade| Novavax Pharmaceuticals continues to gain 10%, its stock surged more than 98% on Friday

Novax Medicine (NVAXnftwemade.US) U.S. stocks continued to rise 9.91%nftwemade, at $9.76, the stock surged more than 98% last Friday, its largest one-day gain since listing. On the news front, Novawax Pharmaceuticals announced last Friday that it had reached a multi-billion-dollar cooperation agreement with French pharmaceutical giant Sanofi. According to the agreement, the two parties will jointly commercialize Novavacs Pharma's COVID-19 vaccine starting next year and jointly develop a combination vaccine against coronavirus and influenza. Friday's surge in share prices cost short sellers approximately $255 million in paper losses, according to S3 Partners LLC. Bank of America raised its target price for the stock to $12 from $4 and upgraded its rating to "neutral" from "underperform".